Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
GM-60106 by JD Bioscience for Fibrosis: Likelihood of Approval
GM-60106 is under clinical development by JD Bioscience and currently in Phase I for Fibrosis. According to GlobalData, Phase I...
Data Insights
GM-60106 by JD Bioscience for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
GM-60106 is under clinical development by JD Bioscience and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...